This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
497 |
4. Check minimum number of eventsNone |
497 |
5. Include endpointsNone |
497 |
6. Filter based on genotype QC (FinnGen only) |
497 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHEMOCHILD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes ticiformes
Similar endpoints
↥List of similar endpoints to
Tic disorders
based on the number of shared cases.
Similar with more cases:
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 497 | 251 | 246 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | 14.86 | 17.47 | 12.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 431
- Matched controls
- 4312
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F95.9
ICD-10 Finland
Tic disorder, unspecified
+∞
172.9
154
*
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
2218.0
162.2
147
*
F95.0
ICD-10 Finland
Transient tic disorder
1261.0
104.8
98
*
F95.1
ICD-10 Finland
Chronic motor or vocal tic disorder
+∞
80.8
75
*
N05AX08
ATC
risperidone; systemic
12.4
61.4
118
127
F90.0
ICD-10 Finland
Disturbance of activity and attention
16.1
47.5
79
59
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.1
45.8
146
336
N06BA04
ATC
methylphenidate; oral
17.7
40.3
64
42
N05AX12
ATC
aripiprazole; systemic
8.7
35.2
80
110
N05AD01
ATC
haloperidol; systemic
23.4
34.9
50
24
N05AH04
ATC
quetiapine; oral
4.4
30.5
129
382
N03AE01
ATC
clonazepam; systemic
12.4
30.0
55
50
30620
ICD-8 Finland
Special symptoms not elsewhere classified, Tics
+∞
27.4
26
*
F95.8
ICD-10 Finland
Other tic disorders
+∞
25.2
24
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
7.1
24.8
63
101
F93.89
ICD-10 Finland
Other childhood emotional disorders
92.0
23.9
26
*
N06AB06
ATC
sertraline; oral
4.4
23.2
92
249
N05BA04
ATC
oxazepam; oral
3.6
22.4
119
417
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.8
20.8
100
321
N06AB03
ATC
fluoxetine; oral
4.4
20.2
78
204
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
37.8
20.0
25
7
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
8.9
20.0
43
53
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
6.9
20.0
51
82
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
9.9
19.3
39
43
N06BA09
ATC
atomoxetine; oral
+∞
18.9
18
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
7.3
18.4
45
68
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
38.5
17.8
22
6
IGP01
NOMESCO Finland
Psychiatric family contact
11.1
17.5
33
32
N05AH03
ATC
olanzapine; systemic
5.1
17.4
57
125
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
12.3
16.3
29
25
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.3
16.2
51
107
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.5
16.0
59
147
F84.5
ICD-10 Finland
Asperger syndrome
14.5
15.7
26
19
N06AX16
ATC
venlafaxine; oral
3.6
15.7
77
248
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.2
15.5
90
329
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
16.9
15.4
24
15
N03AX09
ATC
lamotrigine; oral
5.6
15.0
44
85
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.7
14.9
38
61
IGV01
NOMESCO Finland
Psychiatric network contact
11.0
14.9
28
27
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
+∞
14.7
14
*
N05BA01
ATC
diazepam; systemic, rectal
3.7
14.0
63
188
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
+∞
13.6
13
*
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
7.3
13.4
32
47
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
12.9
71
247
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
8.4
12.5
27
34
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.5
12.5
61
195
N03AG01
ATC
valproic acid; systemic, rectal
4.5
12.5
44
105
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
66.8
11.7
13
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.8
11.6
49
139
N05AG02
ATC
pimozide; oral
+∞
11.5
11
*
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
+∞
11.5
11
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.2
11.2
42
107
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.6
10.6
24
33
G24.5
ICD-10 Finland
Blepharospasm
112.6
10.5
11
*
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
+∞
10.5
10
*
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
12.5
10.4
18
15
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.8
10.4
73
295
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.3
10.4
31
62
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
33.4
10.4
13
*
N06AB10
ATC
escitalopram; oral
2.3
10.4
105
522
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.4
10.1
36
87
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.5
10.0
29
56
N06AX11
ATC
mirtazapine; oral
2.2
9.9
110
570
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
6.4
9.8
25
41
N06AB04
ATC
citalopram; systemic
2.7
9.7
70
289
N06AX12
ATC
bupropion; oral
3.3
9.6
48
156
IEV99
NOMESCO Finland
Other psychiatric network intervention
10.4
9.6
18
18
G51.3
ICD-10 Finland
Clonic hemifacial spasm
102.1
9.4
10
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.6
9.2
26
49
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.0
9.1
36
97
F83
ICD-10 Finland
Mixed specific developmental disorders
5.5
9.1
26
50
R42
ICD-10 Finland
Dizziness and giddiness
2.6
8.9
68
289
C07AA05
ATC
propranolol; systemic
2.3
8.9
85
409
F80.1
ICD-10 Finland
Expressive language disorder
6.8
8.8
21
32
RT420
NOMESCO Finland
NA
51.0
8.7
10
*
R25.3
ICD-10 Finland
Fasciculation
51.0
8.7
10
*
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
8.5
8.7
18
22
F88
ICD-10 Finland
Other disorders of psychological development
20.5
8.5
12
6
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.9
8.5
20
30
N03AF01
ATC
carbamazepine; oral, rectal
6.4
8.4
21
34
N03AX12
ATC
gabapentin; oral
3.1
8.4
47
165
SPAT1240
SPAT
Therapeutic discussion
2.3
8.4
80
384
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
+∞
8.4
8
*
F91.9
ICD-10 Finland
Conduct disorder, unspecified
+∞
8.4
8
*
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
12.0
8.1
14
12
F84.8
ICD-10 Finland
Other pervasive developmental disorders
22.5
8.0
11
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.0
154
984
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.2
7.9
40
132
N06AA04
ATC
clomipramine; systemic
9.7
7.8
15
16
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
7.8
34
100
M79.6
ICD-10 Finland
Pain in limb
1.9
7.7
123
733
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
12.1
7.6
13
11
N04AA02
ATC
biperiden; systemic
9.1
7.6
15
17
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.6
7.6
33
97
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.4
7.5
26
62
N05BE01
ATC
buspirone; oral
7.9
7.4
16
21
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.3
7.4
26
63
SPAT1307
SPAT
Psychosocial counselling and guidance
2.4
7.3
66
306
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
6.4
7.3
18
29
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
+∞
7.3
7
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
7.3
85
445
F31.8
ICD-10 Finland
Other bipolar affective disorders
7.5
7.2
16
22
SPAT1243
SPAT
Psychiatric/psychological examination
3.2
7.2
37
124
Z71.8
ICD-10 Finland
Other specified counselling
1.9
7.2
114
677
F84.0
ICD-10 Finland
Childhood autism
20.4
7.2
10
5
IEP99
NOMESCO Finland
Other psychiatric family intervention
9.0
7.1
14
16
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
6.5
7.0
17
27
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
6.9
96
541
M03BX01
ATC
baclofen; systemic
14.1
6.9
11
8
ICA03
NOMESCO Finland
Psychiatric treatment plan, outsourced psychotherapy
22.9
6.7
9
*
N05CF01
ATC
zopiclone; oral
2.1
6.7
75
385
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.0
6.7
14
18
N06AB05
ATC
paroxetine; oral
3.7
6.6
27
76
Z72.8
ICD-10 Finland
Other problems related to lifestyle
10.2
6.6
12
12
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
6.5
78
412
C02AC01
ATC
clonidine; systemic
70.8
6.4
7
*
F95
ICD-10 Finland
Tic disorders
70.8
6.4
7
*
N06BA12
ATC
lisdexamfetamine; oral
14.6
6.4
10
7
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
6.3
81
442
J01DB01
ATC
cefalexin; oral
1.8
6.3
325
2736
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.2
6.3
22
54
F91.3
ICD-10 Finland
Oppositional defiant disorder
+∞
6.3
6
*
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
+∞
6.3
6
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
+∞
6.3
6
*
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.4
6.2
28
86
F50.9
ICD-10 Finland
Eating disorder, unspecified
5.9
6.2
16
28
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
6.1
41
164
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
12.8
6.1
10
8
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.6
6.0
43
178
R03AC02
ATC
salbutamol; inhalant
1.6
6.0
214
1614
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
74
182
4.60
28.31
2.6
2.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
171
871
2.47
18.95
2.7
3.1
mmol/l
2.4
2.4
0.31
150
780
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
381
2803
2.54
17.42
4.1
3.6
pmol/l
14.5
14.5
0.14
350
2530
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
124
579
2.52
16.26
2.5
1.6
%
1.5
1.4
2.17
113
534
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
221
1355
2.14
14.98
2.6
2.6
nmol/l
68.3
70.2
0.46
213
1256
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
166
937
2.16
13.69
1.9
1.6
pmol/l
101.2
99.4
0.21
92
473
(3044889) 12 lead EKG panel
275
1872
2.05
13.67
3.2
2.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
412
3305
2.44
12.94
5.1
4.1
mu/l
1.9
1.9
0.19
393
3085
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
321
2349
2.04
12.60
7.1
6.3
u/l
86.6
84.6
0.25
304
2201
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
380
2967
2.19
12.42
3.8
2.9
mmol/l
5.6
5.6
0.31
359
2725
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
184
1118
2.03
12.20
3.4
3.2
u/l
27.9
32.5
1.94
174
1066
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
132
714
2.16
11.91
2.9
2.1
u/l
169.3
361.2
1.10
124
674
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
92
428
2.41
11.88
1.5
1.6
pmol/l
426.9
17632024.1
0.50
79
380
(3019550) Sodium [Moles/volume] in Serum or Plasma
426
3512
2.49
11.83
14.4
10.8
mmol/l
139.6
139.5
0.06
421
3384
(3021960) Folate [Moles/volume] in Serum or Plasma
105
520
2.29
11.75
1.6
1.3
nmol/l
18.3
20.4
0.99
94
453
(3011288) Drugs identified in Urine by Screen method
76
325
2.58
11.73
3.4
2.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
426
3523
2.46
11.55
14.5
10.7
mmol/l
3.9
3.9
0.09
420
3383
(3013707) Erythrocyte sedimentation rate by Westergren method
332
2500
1.99
11.50
4.3
3.7
mm/h
8.6
8.2
0.25
306
2309
(3013115) Eosinophils [#/volume] in Blood
287
2062
1.93
11.39
7.4
7.9
e9/l
0.2
0.2
0.16
251
1832
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
218
1443
1.91
10.99
8.1
7.6
mmol/l
1.2
1.2
0.14
188
1248
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
216
1435
1.89
10.69
6.1
5.9
umol/l
10.0
11.0
1.29
206
1346
(3009508) Creatinine [Moles/volume] in Urine
148
868
2.00
10.59
3.7
3.8
mmol/l
9.0
8.8
0.14
129
776
(3001604) Monocytes [#/volume] in Blood
277
2005
1.86
10.35
6.9
7.4
e9/l
0.6
0.6
0.06
238
1741
(3006315) Basophils [#/volume] in Blood
277
2006
1.86
10.32
7.0
7.4
e9/l
0.0
0.0
0.04
238
1743
(1001926) Buprenorphine [Presence] in Urine by Screen method
81
383
2.33
10.00
2.4
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
286
2113
1.83
9.78
6.9
7.3
e9/l
2.0
2.0
0.17
250
1876
(3019309) Folate [Moles/volume] in Red Blood Cells
74
343
2.36
9.55
1.6
1.7
nmol/l
1163.3
1150.6
0.04
61
266
(3024561) Albumin [Mass/volume] in Serum or Plasma
177
1141
1.86
9.34
5.0
6.0
g/l
38.0
37.7
0.29
166
1073
(3012095) Magnesium [Moles/volume] in Serum or Plasma
89
450
2.19
9.34
6.2
6.5
mmol/l
0.8
0.8
0.81
82
427
(3019069) Monocytes/100 leukocytes in Blood
262
1926
1.76
8.73
7.2
7.6
%
8.5
8.3
0.81
250
1838
(3016879) Cocaine [Presence] in Urine
90
470
2.12
8.67
2.4
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
273
2035
1.76
8.63
7.0
7.3
%
32.0
31.8
0.08
259
1944
(42870588) Differential panel, method unspecified - Blood
201
1379
1.77
8.44
6.3
7.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
252
1848
1.74
8.34
7.3
7.6
%
0.7
0.7
0.06
239
1755
(3006504) Eosinophils/100 leukocytes in Blood
258
1910
1.73
8.20
7.1
7.5
%
3.0
2.9
0.06
242
1813
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
143
896
1.84
8.08
2.8
2.5
u/l
52.4
57.4
0.54
133
831
(3000764) Benzodiazepines [Presence] in Urine
93
507
2.03
7.95
2.4
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
194
1338
1.74
7.87
7.1
7.5
mmol/l
1.2
1.2
0.03
179
1241
(3027008) Opiates [Presence] in Urine
93
512
2.00
7.73
2.4
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
124
753
1.86
7.70
2.7
3.3
kg/l
1.0
1.0
—
8
101
(3018010) Neutrophils/100 leukocytes in Blood
265
1999
1.70
7.68
7.0
7.2
%
52.9
53.9
0.70
254
1911
(3028300) Cannabinoids [Presence] in Urine
93
514
2.00
7.64
2.4
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
293
2274
1.70
7.61
10.4
9.5
e9/l
3.7
3.9
0.68
257
1974
(4198724)
20
49
4.21
7.60
1.5
2.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
316
2504
1.72
7.59
4.1
2.9
u/l
30.6
32.6
0.41
301
2400
(3027944) Amphetamines [Presence] in Urine
91
508
1.97
7.25
2.0
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
164
1108
1.72
7.01
3.3
3.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
76
3.27
6.37
1.1
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
22
68
3.34
6.07
1.6
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
106
656
1.78
6.06
5.1
4.3
—
—
—
0
0
(3013512) EKG study
99
602
1.80
6.00
3.5
2.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
440
3943
2.01
5.89
10.6
8.0
u/l
27.7
27.6
0.05
431
3805
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
11
20
5.60
5.83
1.3
2.6
umol/l
11.0
17.1
1.05
11
20
(3021589) Normoblasts [#/volume] in Blood
241
1862
1.57
5.73
10.2
9.5
e9/l
0.0
0.0
0.28
193
1483
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
127
841
1.69
5.68
3.7
2.9
ng/l
32.7
39.7
0.15
65
396
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
15
37
4.15
5.66
1.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
233
1790
1.57
5.66
3.1
2.9
ug/l
78.0
73.4
0.22
219
1683
(3037467) Urinalysis macro (dipstick) panel - Urine
293
2384
1.56
5.42
4.2
3.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
28
108
2.69
5.32
2.0
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
69
3.13
5.28
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
123
831
1.64
5.03
3.0
2.7
mg/l
2.7
2.7
0.09
108
703
(3019225) pH of Specimen
43
208
2.17
5.01
6.7
3.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
363
3129
1.59
4.99
3.5
3.1
mmol/l
4.5
4.6
1.21
349
2957
(3026782) Osmolality of Urine
102
658
1.69
4.98
2.5
2.7
mosm/kgh2o
562.5
597.4
0.58
83
569
(3005719) IgG [Mass/volume] in Serum or Plasma
58
315
1.95
4.97
1.8
3.3
g/l
10.5
10.0
0.70
52
292
(3002582) Erythrocytes [#/volume] in Urine
144
1016
1.59
4.92
3.3
3.4
e6/l
31.1
103.0
0.55
112
774
(3018418) pH of Serum or Plasma
116
777
1.64
4.90
3.9
3.9
ph
7.4
7.4
1.30
21
148
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
352
3021
1.57
4.85
12.9
8.5
ml/min/173m2
100.7
100.3
0.10
286
2272
(40758558) Short blood count panel - Blood
146
1039
1.57
4.79
8.4
8.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
239
1897
1.50
4.72
4.5
4.9
mmol/l
6.2
6.4
0.64
218
1716
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
362
3139
1.56
4.65
3.7
3.3
mmol/l
2.7
2.8
0.52
345
2941
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
358
3106
1.55
4.49
3.4
3.1
mmol/l
1.4
1.4
0.85
340
2930
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
310
2613
1.50
4.44
4.3
3.9
mmol/mol
37.0
37.5
0.37
296
2477
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
188
2.11
4.21
1.9
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
212
1675
1.46
4.11
4.6
4.5
estimate
0.0
0.0
0.00
47
344
(4027681)
12
32
3.82
4.11
1.0
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
164
1235
1.49
4.04
4.0
3.9
e6/l
19.3
60.7
1.76
119
821
(36304419) Bacteria [Presence] in Urine
130
933
1.53
4.03
3.2
3.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
66
400
1.75
4.01
3.0
2.8
mmol/l
2.4
2.4
0.13
59
346
(3030467) Casts [#/volume] in Urine by Automated count
129
927
1.53
3.97
3.4
3.3
e6/l
0.3
0.2
0.33
97
695
(3023520) Reticulocytes [#/volume] in Blood
41
214
2.00
3.95
2.9
4.2
e9/l
80.7
66.7
0.67
29
138
(40761535) Cells panel - Urine sediment
37
186
2.07
3.94
1.9
3.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
59
2.95
3.93
1.2
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
55
318
1.82
3.91
2.1
2.5
u/l
188.6
32.2
0.47
47
263
(3009261) Glucose [Presence] in Urine by Test strip
212
1694
1.44
3.79
3.5
3.2
estimate
0.0
0.0
0.00
45
328
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
427
3908
1.66
3.77
14.2
10.2
mg/l
18.9
22.0
1.57
319
2821
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
47
262
1.88
3.75
5.2
5.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
72
458
1.67
3.68
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
167
1284
1.45
3.64
1.5
1.5
u/ml
0.6
1.6
1.89
38
290
(1616796) Gas panel - Central venous blood
17
62
2.80
3.62
1.9
3.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
17
5.37
3.52
3.2
7.4
ug/l
16.7
19.6
—
9
17
(3042517) Benzodiazepines panel - Urine
6
6
10.10
3.50
2.0
4.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
477
4534
2.29
3.44
20.6
14.5
pg
29.6
29.7
0.89
471
4478
(3029937) Albumin [Presence] in Urine by Test strip
119
865
1.49
3.43
3.1
3.4
estimate
0.0
0.0
0.50
45
334
(3024731) MCV [Entitic volume]
477
4535
2.29
3.42
20.6
14.5
fl
88.3
88.4
0.21
471
4480
(3026361) Erythrocytes [#/volume] in Blood
477
4535
2.29
3.42
20.6
14.6
e12/l
4.7
4.7
0.09
460
4385
(3010813) Leukocytes [#/volume] in Blood
477
4537
2.28
3.38
20.7
14.6
e9/l
6.7
6.6
0.15
460
4384
(3007164) IgA [Mass/volume] in Serum or Plasma
150
1145
1.44
3.36
1.5
1.6
g/l
1.9
2.0
0.21
86
668
(3035350) Ketones [Presence] in Urine by Test strip
207
1674
1.41
3.36
3.4
3.2
estimate
0.0
0.0
0.00
45
331
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
338
2974
1.43
3.34
3.3
2.9
mmol/l
1.2
1.2
0.02
322
2806
(3007461) Platelets [#/volume] in Blood
476
4526
2.22
3.34
20.7
14.6
e9/l
259.5
258.1
0.19
462
4381
(3000963) Hemoglobin [Mass/volume] in Blood
477
4540
2.26
3.32
20.8
14.7
g/l
137.5
137.8
0.19
471
4484
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
43
3.08
3.27
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
63
400
1.66
3.25
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
35
186
1.95
3.24
1.6
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
125
929
1.46
3.20
4.7
5.4
inr
1.1
1.1
0.22
47
303
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
15
5.40
3.20
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
15
5.40
3.20
1.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
45
262
1.79
3.16
2.1
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
78
527
1.57
3.13
3.4
3.0
e6/l
1.9
3.0
1.04
49
281
(3003458) Phosphate [Moles/volume] in Serum or Plasma
72
479
1.59
3.09
7.4
7.8
mmol/l
1.1
1.2
0.68
67
452
(3007853) Bacteria identified in Skin by Aerobe culture
65
423
1.62
3.05
2.1
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
98
701
1.50
3.03
2.4
2.8
e6/l
11.1
5.8
1.57
81
615
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
122
2.10
2.92
2.2
2.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
30
534
0.53
2.88
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
48
293
1.71
2.88
1.3
1.4
u/ml
235.6
350.8
0.53
43
270
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
13
5.44
2.88
1.7
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
59
384
1.61
2.78
4.2
4.0
umol/l
9.0
7.1
0.17
50
319
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
14
5.05
2.73
1.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
101
745
1.45
2.67
1.7
1.6
mmol/l
1.5
1.4
0.65
87
662
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
78
548
1.50
2.63
3.4
2.9
e6/l
0.6
0.7
0.39
49
298
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
135
1.98
2.60
1.6
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
65
440
1.55
2.60
1.8
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
51
326
1.63
2.59
5.9
6.3
mmol/l
1.2
1.1
0.07
34
238
(3002385) Erythrocyte distribution width [Ratio]
388
3560
1.41
2.57
17.4
12.8
%
13.2
13.2
0.20
382
3496
(40761511) CBC panel - Blood by Automated count
434
4067
1.53
2.57
12.3
8.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
44
2.77
2.56
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
103
770
1.43
2.53
2.9
3.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
39
2.86
2.49
1.1
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
32
182
1.81
2.46
1.5
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
71
497
1.50
2.44
1.3
1.2
iu/ml
18.8
26.9
0.41
17
151
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
70
2.33
2.43
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
35
206
1.75
2.41
5.8
15.0
inr
1.1
1.2
—
8
43
(40768804) Tissue Pathology biopsy report
139
1102
1.36
2.41
1.8
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
117
903
1.39
2.39
4.8
4.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
51
333
1.59
2.39
6.0
6.2
kpa
5.2
5.1
0.73
45
313
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
8
6.30
2.37
1.2
1.0
u/l
8.6
18.4
—
5
8
(3037522) Nuclear Ab [Titer] in Serum
69
483
1.50
2.37
1.5
1.4
titre
301.8
506.5
1.30
11
89
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
46
294
1.62
2.35
1.8
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
52
345
1.57
2.28
1.2
1.3
—
—
—
0
0
(4062490)
11
42
2.66
2.20
1.2
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
301
1.58
2.15
1.8
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
277
1.60
2.14
3.2
3.0
%
31.9
31.2
0.12
30
198
(3004588) Protein electrophoresis panel - Serum or Plasma
18
88
2.08
2.14
1.2
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
65
460
1.48
2.13
3.3
3.8
ng/l
494.0
1340.8
1.47
54
357
(3000991) Gas panel - Venous blood
57
393
1.51
2.12
6.9
9.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
25
3.23
2.10
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
31
2.94
2.08
1.7
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
71
514
1.44
2.08
3.4
3.7
mg/l
926.6
94.6
0.47
49
359
(40760888) Immunoglobulin light chains.free panel - Serum
7
20
3.53
2.06
8.4
6.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
20
3.53
2.06
1.0
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
154
1266
1.31
2.05
3.3
3.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
26
3.11
2.02
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
339
1.53
2.01
1.2
1.2
iu/ml
135.9
126.5
0.07
16
115
(3002032) Base excess in Venous blood by calculation
61
432
1.47
2.00
4.4
7.1
mmol/l
2.0
1.6
0.59
50
340
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
36
228
1.62
1.94
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
39
2.60
1.93
1.1
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
31
190
1.67
1.89
3.8
4.5
mmol/l
1.2
1.2
0.56
25
169
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
22
3.21
1.88
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
46
2.42
1.86
1.6
8.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
72
534
1.41
1.86
4.2
4.6
mg/mmol
12.1
14.6
0.14
49
379
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
12
4.20
1.82
1.0
1.2
—
—
—
0
0
(4010399)
32
200
1.64
1.82
1.7
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
92
714
1.35
1.81
3.1
2.7
mg/l
1.1
1.0
0.10
57
496
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
8
29
2.79
1.80
1.1
1.0
mg/l
266.9
301.5
—
8
23
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
41
2.47
1.76
1.3
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
12
54
2.25
1.75
1.3
3.9
e9/l
1.1
1.3
—
5
32
(3028433) Virus identified in Specimen by Culture
6
18
3.36
1.75
1.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
172
1461
1.27
1.75
2.8
2.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
42
2.41
1.68
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
38
254
1.54
1.66
1.5
1.3
miu/ml
199.1
271.5
0.55
12
132
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
37
247
1.54
1.63
3.6
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
75
963
0.74
1.63
1.6
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
63
2.09
1.61
3.0
5.8
mmol/l
3.9
2.5
—
7
32
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
51
366
1.44
1.59
3.8
2.6
u/l
2866.4
5334.0
0.47
17
151
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
26
2.72
1.58
1.7
2.0
pg
32.6
32.5
—
7
26
(3022145) Colonoscopy Study observation
43
299
1.48
1.57
1.6
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
420
3991
1.34
1.56
14.6
11.2
%
40.6
40.8
0.17
336
3427
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
71
2.00
1.55
1.6
1.5
ug/g
289.6
311.3
—
5
43
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
42
0.00
1.53
0.0
4.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
15
3.36
1.52
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
27
2.61
1.52
1.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
53
387
1.41
1.51
2.7
2.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
65
492
1.37
1.51
3.2
2.9
ng/l
76.3
910.3
2.06
29
281
(3044290) Cell count panel - Cerebral spinal fluid
18
101
1.81
1.51
1.2
3.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
16
3.15
1.44
2.2
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
118
1.72
1.43
1.8
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
236
0.54
1.41
1.8
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
174
1.58
1.40
1.3
1.6
u/ml
331.4
170.3
1.12
13
101
(3016018) Differential panel - Cerebral spinal fluid
11
53
2.10
1.39
1.2
3.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
90
727
1.29
1.35
3.3
3.1
ug/g
146.0
127.8
0.20
70
575
(3017181) Myelocytes/100 leukocytes in Blood
36
250
1.47
1.35
8.1
4.7
%
1.0
0.7
0.42
13
67
(4035726)
30
201
1.52
1.33
1.4
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
17
98
1.76
1.32
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
31
210
1.51
1.31
1.1
1.2
u/ml
4.0
1.8
0.47
19
122
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
210
1.51
1.31
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
100
823
1.27
1.30
2.9
2.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
478
1.34
1.30
1.3
1.2
u/ml
11.4
6.9
0.23
24
196
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
217
0.54
1.29
1.7
1.8
—
—
—
0
0
(44813793)
8
34
2.37
1.29
1.1
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
9
45
2.02
1.24
2.1
5.0
%
8.0
13.5
—
9
45
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
45
2.02
1.24
1.1
4.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
78
1.82
1.22
1.6
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
37
2.18
1.22
1.8
4.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
165
1.54
1.20
3.8
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
34
240
1.45
1.19
8.4
4.7
%
0.3
0.1
0.74
11
62
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
190
1.50
1.19
1.1
1.2
u/ml
3.2
7.7
1.86
20
140
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
79
1.79
1.18
1.5
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
110
1.66
1.17
11.4
13.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
33
233
1.45
1.16
7.5
4.3
%
0.8
0.3
—
9
49
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
39
2.07
1.15
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
39
2.07
1.15
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
140
1215
1.21
1.12
3.3
2.3
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
8
40
2.02
1.12
1.1
4.5
%
33.3
27.7
—
8
40
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
40
2.02
1.12
1.3
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
112
1.63
1.10
1.1
1.1
u/ml
1.6
7.9
2.56
11
62
(3023420) DNA double strand Ab [Units/volume] in Serum
8
41
1.97
1.09
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
87
721
1.25
1.08
2.0
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
20
130
1.56
1.04
1.1
1.1
u/ml
2.5
9.1
1.89
11
65
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
89
743
1.24
1.04
2.8
2.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
34
2.07
1.03
1.7
5.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
180
1.47
1.03
1.3
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
173
1.47
0.99
1.4
1.8
mg/l
3.0
2.9
0.06
18
108
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
23
2.19
0.98
2.4
2.9
u/ml
741.4
961.3
—
5
23
(3010726) Horse dander IgE Ab [Units/volume] in Serum
26
182
1.45
0.98
1.2
1.1
u/ml
0.3
5.1
—
10
60
(3014576) Chloride [Moles/volume] in Serum or Plasma
41
312
1.34
0.97
7.0
7.5
mmol/l
105.4
104.2
0.94
41
307
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
51
1.78
0.95
1.6
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
142
1.50
0.94
1.5
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
27
2.24
0.93
1.3
1.2
iu/ml
338.0
168.6
—
6
27
(3022313) Gas panel - Capillary blood
37
279
1.35
0.93
7.6
6.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
18
118
1.55
0.92
1.7
2.1
u/l
40.9
41.0
0.01
18
110
(3035320) C reactive protein [Mass/volume] in Body fluid
6
28
2.16
0.92
4.3
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
112
972
1.20
0.90
3.2
2.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
33
246
1.37
0.90
1.7
1.9
iu/l
10.1
13.5
0.55
24
182
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
29
2.08
0.89
1.0
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
29
2.08
0.89
1.5
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
26
186
1.42
0.89
1.1
1.2
u/ml
0.8
1.4
0.39
17
121
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
103
1.57
0.88
1.3
2.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
20
137
1.48
0.85
3.0
3.2
e6/l
0.1
0.1
0.04
20
130
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
31
1.95
0.84
1.8
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
57
1.77
0.84
2.1
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
31
233
1.35
0.81
9.1
4.8
%
0.0
0.1
—
8
55
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
58
1.74
0.80
1.1
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
24
0.00
0.79
0.0
5.5
—
37.3
—
0
6
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
33
1.83
0.79
1.0
1.3
nmol/l
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
165
1.41
0.79
1.4
1.4
—
—
—
0
0
(4034850)
14
90
1.57
0.79
12.1
11.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
123
0.56
0.79
1.4
1.9
—
—
—
0
0
(1002224) Polysomnography panel
20
140
1.45
0.78
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
447
0.77
0.78
1.2
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
469
0.77
0.78
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
170
1545
1.15
0.77
2.2
1.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
3.0
—
17.7
—
0
27
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
2.5
—
2.6
—
0
27
(3052851) Hemolysis interference index of Serum or Plasma
16
107
1.51
0.77
2.9
3.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
26
192
1.37
0.76
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
48
388
1.26
0.76
1.6
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
25
334
0.74
0.76
1.1
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
20
141
1.44
0.75
3.7
4.4
ug/l
7.4
6.1
0.09
15
110
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
108
1.50
0.74
1.7
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
117
1.47
0.72
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
60
1.68
0.72
1.2
7.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
134
1.43
0.72
1.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
12
76
1.59
0.72
1.8
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
40
1.76
0.71
1.3
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
57
1.59
0.71
1.1
2.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
205
0.67
0.71
1.9
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
26
1.93
0.71
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
26
1.93
0.71
2.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
41
1.72
0.70
1.3
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
41
1.72
0.70
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
59
1.53
0.68
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
7
42
1.68
0.68
2.0
1.7
mosm/kgh2o
286.7
290.4
—
7
28
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
21
153
1.39
0.68
3.7
3.1
ng/l
64.9
125.1
1.61
14
134
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
190
0.68
0.66
1.3
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
28
1.79
0.66
1.4
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
78
1.55
0.66
2.1
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
137
1.40
0.65
1.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
112
1.44
0.64
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
29
1.73
0.64
1.0
2.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
45
371
1.23
0.63
1.4
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
113
1.43
0.62
1.1
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
30
1.67
0.61
1.8
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
139
1.38
0.61
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
139
1.38
0.61
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
105
1.44
0.60
5.7
2.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
26
201
1.31
0.60
8.4
13.8
mg/l
1.1
1.1
0.17
26
193
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
97
1.46
0.59
2.7
2.0
iu/l
3.0
7.4
—
6
33
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
72
1.54
0.59
1.5
1.3
—
4.5
—
0
5
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.59
2.0
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
64
1.57
0.59
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.59
1.7
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
64
1.57
0.59
1.0
4.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
89
1.47
0.58
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
89
1.47
0.58
1.6
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
36
1.67
0.57
1.5
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
37
1.63
0.55
1.0
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
37
1.63
0.55
1.8
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
15
108
1.40
0.53
1.5
1.5
—
63.8
—
0
13
(40768443) Skin Pathology biopsy report
15
108
1.40
0.53
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
118
1293
0.89
0.53
1.6
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
120
1096
1.13
0.51
2.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
118
1.37
0.50
1.8
1.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
142
1311
1.12
0.50
3.4
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
114
1245
0.89
0.49
2.1
2.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.4
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
50
1.41
0.45
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
40
340
1.19
0.44
1.8
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
37
313
1.20
0.43
3.4
3.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
78
1.42
0.43
1.4
1.7
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
5
31
1.62
0.43
1.4
3.4
mmol/l
2.9
2.1
—
5
31
(4306422)
8
57
1.41
0.42
1.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
186
1.25
0.41
1.6
2.6
ml/min/173m2
86.7
82.1
—
9
68
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
69
619
1.13
0.40
2.7
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
205
1.23
0.40
1.3
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.6
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
66
1.37
0.38
2.4
2.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
36
1.39
0.38
1.0
1.2
u/l
26.8
18.0
—
5
31
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
37
1.35
0.37
1.4
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
42
1.43
0.35
3.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
108
1.30
0.35
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
358
1.16
0.35
1.2
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
2.3
4.1
—
—
—
0
0
(4268621)
6
43
1.40
0.35
2.3
2.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
40
349
1.16
0.35
2.2
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
87
0.69
0.33
2.7
2.9
mu/l
26.0
31.4
—
6
81
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
14
112
1.26
0.28
1.0
1.0
u/ml
0.1
0.8
—
5
44
(3003396) Base excess in Arterial blood by calculation
27
233
1.17
0.28
9.0
9.6
mmol/l
0.6
0.8
0.16
21
180
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
86
801
1.09
0.27
2.5
2.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
22
187
1.18
0.27
10.0
10.9
g/l
123.0
125.2
0.21
22
179
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
67
1.20
0.26
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
73
1.24
0.25
1.2
2.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
151
1.20
0.25
1.1
1.1
—
8.7
—
0
26
(3044640) Blood type and Crossmatch panel - Blood
107
1010
1.08
0.25
2.7
2.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
133
1.21
0.24
1.9
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
20
172
1.17
0.22
1.6
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
107
1.22
0.22
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.5
—
1.1
—
0
11
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
11
0.00
0.21
0.0
1.4
—
27.8
—
0
11
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
9.9
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
0
14
0.00
0.20
0.0
5.9
—
16.0
—
0
7
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
49
1.23
0.20
10.3
3.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
49
454
1.09
0.19
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
20
227
0.88
0.18
1.6
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
58
1.21
0.18
2.0
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
258
0.89
0.18
1.6
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
205
1.13
0.17
1.4
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
69
0.72
0.17
1.0
1.4
u/l
18.3
14.2
—
5
62
(3017446) Testosterone [Moles/volume] in Serum or Plasma
38
350
1.09
0.17
2.5
2.3
nmol/l
15.3
13.4
0.40
32
314
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
101
1.19
0.16
1.8
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
8
68
1.18
0.16
2.1
1.8
ug/l
1.4
5.6
—
8
60
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
178
1.13
0.15
1.6
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
198
1.12
0.14
1.3
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
259
1.09
0.12
1.7
2.0
u/l
5.4
6.3
0.46
22
189
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
95
1.16
0.11
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
19
172
1.11
0.11
1.6
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
12
105
1.15
0.11
1.6
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
383
3797
1.04
0.11
4.1
3.8
—
—
—
0
0
(3020891) Body temperature
11
96
1.15
0.10
2.5
5.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
37
349
1.07
0.10
3.2
3.2
%
20.1
22.5
—
9
119
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
228
0.92
0.10
1.6
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
2.2
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
47
1.06
0.09
2.8
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
145
1.11
0.09
5.4
6.8
g/l
0.5
0.3
—
9
88
(4094501)
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
227
0.92
0.09
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
227
0.92
0.09
1.6
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
54
1.11
0.09
2.3
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
2.2
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
28
297
0.94
0.08
1.5
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
619
1.04
0.08
1.6
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
71
0.84
0.07
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
86
1.05
0.07
1.8
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
89
1.13
0.07
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
227
1.06
0.06
1.8
2.1
e9/l
3.4
3.9
0.53
19
201
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
243
0.94
0.05
2.1
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
110
1.09
0.05
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
119
0.92
0.04
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
33
320
1.03
0.03
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
269
0.96
0.02
3.4
2.3
ug/l
0.7
0.7
0.01
14
134
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
168
0.95
0.02
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
117
0.94
0.01
4.3
7.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
223
1.03
0.01
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
96
968
0.99
0.01
2.2
1.9
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
12
114
1.05
0.00
6.0
4.3
%
55.8
52.2
0.19
12
114
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
123
0.98
0.00
1.2
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
11
111
0.99
0.00
5.2
4.3
mmol/l
24.6
24.6
0.00
11
106
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
153
1526
1.00
0.00
4.3
3.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
50
1.00
0.00
1.4
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
56
0.89
0.00
1.6
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
7.4
—
0
8
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
9.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
56
0.89
0.00
1.6
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
87
0.92
0.00
1.9
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
50
1.00
0.00
1.6
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
3.2
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_TIC – Tic disorders
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).